Groups
Company Size (Fulltime employees)
Looking for
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

Dandan Xie China

Focused in genitourinary（GU）/women health field with 2 global assets for bladder cancer and pre-cervical cancer treatment in phase 3 stages，looking for in/out-licensing partnership in GU/women health area
Website:
www.asieris.cn
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
Service Description
治疗产品 Therapeutic products
Asieris Pharmaceuticals
BD Director 

John Xu United States

Bi-Specific antibody drug discovery
Website:
www.Abpro.com
Year of foundation
2004
Looking for
Please specify your partnering goal
Pre IPO fund raising
Headquartner in China
No
Plan in China
Set up subsidiary in China next year
Biotech/Pharma Category
Investment Focus
Looking for investors
Abpro
SVP 
Functionality
Business Development

Meng Xu China

Established in February 1994 with approval from the State Council, Suzhou Industrial Park (SIP) is the first governmental cooperation project between China and Singapore. Covering an administrative area of 278 sqkm, it is home to 1.19 million people, including 807,800 permanent residents. SIP focuses on three main area, Bio-medicine, AI and nanomaterials.
Over 1400 bio-medicine companies are located in SIP including Alphamab Oncology, Innovent and Cstones.
Science & technology development center provide services to entrepreneurial teams who is looking for a place to start up their business.
Website:
www.sipac.gov.cn
Looking for
Headquartner in China
Yes
Suzhou Industrial Park Administrative Committee - Science & technology development center
Science & Technology development center - staff 

Siyuan Xu China

VISEN Pharmaceuticals, headquartered in Shanghai, China, is committed to the treatment of endocrine-related disease, introducing the world’s leading treatment methods and drugs into the China market, benefiting Chinese patients while unleashing product potential.

VISEN Pharmaceuticals (VISEN) was formed by Ascendis Pharma A/S (Nasdaq: ASND) and an investor syndicate led by Vivo Capital (along with participation by Sofinnova Ventures), to develop and commercialize Ascendis Pharma’s endocrinology rare disease therapies in Greater China. The pipeline of VISEN covers pediatric endocrinology, adult endocrinology, and rare disease. VISEN management team has extensive experience in the development and commercialization of endocrine disease products in Greater China. VISEN has a deep understanding of unmet medical needs in Chinese patients and is actively expanding its pipeline through in-licensing and partnership.
Website:
www.visenpharma.com
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
VISEN Pharmaceutical
Senior BD Manager 
Functionality
Business Development

Wenjie Xu United States

As China Focus conference organizer, MyBioGate is a premier cross-border healthcare consulting firm serving Biotech and Medtech clients, and the Chinese Pharma companies and investors. We offer marketing, strategy and execution support to help healthcare innovation to grow by taking advantage of China’s huge market potential. We help innovative companies with China-Landing services, and help them find reliable Chinese investors and partners. MyBioGate is committed to linking healthcare innovations in China and overseas. We share global healthcare innovation, entrepreneurship, investment trends, KOL opinions, important events and conferences, in-depth research and analysis, allowing Chinese medical and health companies and investors to gain insight into trends and seize investment opportunities. Our China Focus forums, Global Healthcare Innovation Competitions, and road shows to China provide innovative companies who intend to enter China market with platforms for exposure to potential investors and partners.

Website:
https://en.mybiogate.com/
Mybiogate Inc.
Investment Manager 

Ben Yang China

One Top Chinese Pharma
Website:
www.jemincare.com/en/
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
Service Description
治疗产品 Therapeutic products
Jiangxi Jemincare Group Co., Ltd.
Business Development Manager 

Joanne Yang United States

Syneos Health is the only company in the biopharmaceutical services industry purpose-built to create greater success for our customers. At Syneos Health, clinical and commercial live under the same roof and constantly share real world knowledge and insights that lead to getting the job done better, smarter and faster.

Syneos Health has around 24,000 + employees globally. We are headquartered in US, North Carolina and has more offices in more than 60 countries worldwide. In China, we have offices in Shanghai, Beijing and Dalian.

We call this new way of collaborative working the Biopharmaceutical Acceleration Model or BAM.
Website:
https://www.syneoshealth.com/our-company
Looking for
Headquartner in China
No
Syneos Health
Director, Business Development 
Functionality
Business Development

Simon Yi United States

PhysioCue is digital health and therapy device development company, located in the heart of Silicon Valley, California. PhysioCue has developed the thermal neurostimulation technology for a non-invasive hypertension therapy device and a migraine and headache therapy device and migraine and headache pain monitoring mobile app. Using our device once daily for 5-minute treatments gradually elongated the reduced blood pressure. PhysioCue's therapy devices are efficient, safe, easy to use, and has none of the side effects associated with drugs. We have manufactured our devices and delivered devices to our potential partners and users. We've received positive feedback from many people who have tried and liked our devices. PhysioCue devices can help people and save lives.
Website:
https://physiocue.com
Company Size (Fulltime employees)
1-10
Year of foundation
2013
Looking for
Funding Status
PhysioCue is seeking to raise $7M for a syndicate in our Series A round of financing.
Headquartner in China
No
Plan in China
Set up a JV in China and looking for a distribution partner.
Medtech Category
PhysioCue
LinkedIn logo President 
Functionality
Management

Wayne Yin China

We are rapidly transitioning to an innovation and R&D driven Pharmaceutical company, leveraging our leading manufacturing and commercial capabilities to achieve our mission of “providing today' s patients with medicines of the future“ We have been continuously recognized as one of the “Top 10 Innovative Pharmaceutical Enterprises in China” 1 and “Top 100 Pharmaceutical Manufacturing Enterprises of China”

Website:
www.simcere.com
Looking for
Please specify your partnering goal
Licensing
Headquartner in China
Yes
Biotech/Pharma Category
Simcere Pharmaceutical Group
BD Director 
Functionality
Investment

Xudong Yuan United States

Acon Pharmaceuticals Inc. (Acon Pharma) is a specialty pharmaceutical company and focuses on BLA, ANDA, and 505(b)(2) NDA drug product development with its captive drug delivery system technology platforms. Acon Pharma provides service to its partners and customers to accelerate their IND and NDA product development by out-licencing its captive drug delivery platforms, pre-formulation, formulation, process development, and manufacturing of different types of dosage forms and drug delivery products. Our expertise covers drug development and delivery of poorly soluble small molecule drugs, siRNA, oligonucleotides, peptides, protein, and plasmid DNA. Our formulation technology platforms include nanoparticles, microspheres / microparticles, nanocrystals, liposome, implant, long-acting injectable, oral fast dissolving film (ODF), transdermal patches, resinate / polistirex suspension, nasal spray, topical cream, gel, ointment, nanoemulsion, microemulsion, self-emulsifying system, tablets, capsules, inhalers, controlled release, modified release, and delayed release.
Website:
www.aconpharma.com
Year of foundation
2019
Looking for
Please specify your partnering goal
Looking for investors and strategic partners
Funding Status
Seed round
Now raising (In USD)
5 million USD
Headquartner in China
No
Plan in China
We are establishing a China headquarter company in Shanghai.
Biotech/Pharma Category
Assets Information 1: Name|Description|Indications|Stage|IP countries
AP1500|siRNA liposome inhalation|pulmonary fibrosis|Pre-IND|US, China
Assets Information 2
AP2602|Long acting microsphere injection|schizophrenia|Pre-IND|US, China
Assets Information 3
AP6111|Self-emulsifying Nanoemulsion|osteoporosis|Pre-IND|US, China
Acon Pharma
CEO 
Functionality
Management